Vivani Medical to Present at the Emerging Growth Conference on March 27, 2025
vivani | March 24, 2025
Read More
Vivani Medical Achieves First Implant and Full Enrollment in the First-in-Human Clinical Trial of GLP-1 Implant NPM-115 in Obese or Overweight Adults
vivani | March 13, 2025
Read More
Vivani Medical Announces Intent to Spin Off Cortigent Neurostimulation Business
vivani | March 12, 2025
Read More
Vivani Medical Announces Initiation of First in Human Clinical Trial with GLP-1 Implant in Obese and Overweight Individuals in Australia
vivani | December 19, 2024
Read More
Vivani Medical to Present at the Innovation in Obesity Therapeutics Summit West Coast
| December 4, 2024
Read More
Vivani Medical Provides Business Update Including $5M Equity Financing and Reports Third Quarter 2024 Financial Results
| November 13, 2024
Read More
Vivani Medical to Present at the Partnership Opportunities in Drug Delivery (PODD) Event and ThinkEquity Conference in October 2024
| October 22, 2024
Read More
Vivani Medical Receives Regulatory Approval to Initiate First in Human Clinical Trial with GLP-1 Implant in Obese and Overweight Individuals in Australia
| September 26, 2024
Read More
Vivani Medical to Present at the Emerging Growth Conference on September 25, 2024
| September 23, 2024
Read More
Vivani Medical Announces Positive Preclinical Liver Fat Results with Miniature, Ultra Long-Acting GLP-1 Implant
| September 4, 2024
Read More
Blog Navigation
Contact Us
To learn more about Vivani or LIBERATE-1, the upcoming First-in-Human trial of our long-term GLP-1 implant, please fill out the form.